-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| N814573 | 35013-72-0 | (+)生物素-N-琥珀酰亚胺基酯, 98% N-Succinimidyl D-Biotinate, 98% |
C14H19N3O5S | |
| F960243 | 863971-44-2 | (5S,8S,11S,12R)-11-((S)-仲丁基)-1-(9H-芴-9-基)-5,9-二异丙基-12-甲氧基-4,10-二甲基 3,6,8-三氧代-2-氧杂-4,7,10-三氮杂十四烷-14-酸, 98% Fmoc-3VVD-OH, 98% |
C36H51N3O7 | |
| U960367 | 1394011-91-6 | 1-(4-氯-3-(三氟甲基)苯基)-3-((1r，4r)-4-(5-(三氟甲基)吡啶-2-基氧基)环己基)脲, 97% UC2288, 97% |
C20H18ClF6N3O2 | |
| B936599 | 1415329-20-2 | 1-氧代-3,6,9,12-四氧杂十五烷-15-酸叔丁酯, 95% tert-Butyl 1-oxo-3,6,9,12-tetraoxapentadecan-15-oate, 95% |
C15H28O7 | |
| E960763 | 1559-37-1 | 2-(2-(2-((2-乙基己基)氧基)乙氧基)乙氧基)乙醇, 95% 2-(2-(2-((2-Ethylhexyl)oxy)ethoxy)ethoxy)ethanol, 95% |
C14H30O4 | |
| A861731 | 22198-72-7 | 4-氨基安替比林盐酸盐, >98.0%(HPLC)(T) 4-Aminoantipyrine Hydrochloride, >98.0%(HPLC)(T) |
C11H14N3OCl | |
| N861155 | 68189-42-4 | 4-硝基苯基磷酸双[三羟甲基甲胺]盐 水合物 [磷酸酶用培养基], >90.0%(T) 4-Nitrophenyl Phosphate Di(tris) Salt Hydrate [Substrate for Phosphatase], >90.0%(T) |
C6H6NO6P·(C4H11NO3)2·xH2O | |
| F924619 | 635287-26-2 | 5,8,11,14,17-五氧杂-2-氮杂十九烷二酸 1-芴甲基酯, 96% Fmoc-NH-PEG5-CH2COOH, 96% |
C27H35NO9 | |
| B920134 | 1334170-00-1 | Bis-dPEG®13-PFP ester, Bis-dPEG®13-PFP ester, |
C34H4FO13 | |
| D916822 | 1435934-53-4 | DBCO-CONH-S-S-NHS ester, 95% DBCO-CONH-S-S-NHS ester, 95% |
C28H27N3O6S2 | |
| F983892 | 1116086-09-9 | Fmoc-Phe-Lys(Trt)-PAB-PNP, Fmoc-Phe-Lys(Trt)-PAB-PNP, |
C63H57N5O9 | |
| L990358 | 674782-26-4 | Leronlimab, 99% Leronlimab, 99% |
||
| M996948 | 1600418-29-8 | MC-GGFG-DX8951, 98% MC-GGFG-DX8951, 98% |
C49H51FN8O11 | |
| M995947 | 790704-42-6 | MCB-3681, ≥98% MCB-3681, ≥98% |
C31H32F2N4O8 | |
| S981849 | 875356-43-7 | Secukinumab, ≥98% Secukinumab, ≥98% |
||
| S983963 | 1229022-83-6 | Secukinumab, ≥99% Secukinumab, ≥99% |
||
| S990379 | 541502-14-1 | Siltuximab, ≥99%, 5.6 mg/ml in Buffer solution Siltuximab, ≥99%, 5.6 mg/ml in Buffer solution |
||
| S983965 | 1628113-16-5 | SPDB-sulfo, SPDB-sulfo, |
C13H14N2O7S3 | |
| T983884 | 745013-59-6 | Tremelimumab, ≥98% Tremelimumab, ≥98% |
||
| T935502 | 94-28-0 | 三乙二醇二异辛酸酯, 96% Triethylene glycol bis(2-ethylhexanoate), 96% |
C22H42O6 |
